Microarray expression profile of long noncoding RNAs in human osteosarcoma

Biochemical and Biophysical Research Communications

Volumn 433, Issue 2, 2013, Pages 200-206

  Li, Jin ping ^a   Liu, Li hong ^a   Li, Jie ^b   Chen, You ^a   Jiang, Xiao wei ^a   Ouyang, Yu rong ^a   Liu, Yin qi ^a   Zhong, Hui ^a   Li, Hui ^a   Xiao, Tao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ZHUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Long noncoding RNAs; Microarray; Osteosarcoma; Pathway

Indexed keywords

COMPLEMENTARY DNA; DOUBLE STRANDED DNA; LONG UNTRANSLATED RNA; MESSENGER RNA;

ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84877670477     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.083     Document Type: Article

References (20)

1. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet. J. Rare Dis. 2007, 2:6.
2. Caudill J.S., Arndt C.A. Diagnosis and management of bone malignancy in adolescence. Adolesc. Med. State Art. Rev. 2007, 18:62-78.
3. Wadayama B., Toguchida J., Yamaguchi T., Sasaki M.S., Yamamuro T. P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br. J. Cancer 1993, 68:1134-1139.
4. Nakase M., Inui M., Okumura K., Kamei T., Nakamura S., Tagawa T. P53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol. Cancer Ther. 2005, 4:625-631.
5. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
6. Dinger M.E., Pang K.C., Mercer T.R., Crowe M.L., Grimmond S.M., Mattick J.S. NRED: a database of long noncoding RNA expression. Nucleic Acids Res. 2009, 37:D122-D126.
7. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. MiRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
8. Han L., Zhang K., Shi Z., Zhang J., Zhu J., Zhu S., Zhang A., Jia Z., Wang G., Yu S., Pu P., Dong L., Kang C. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int. J. Oncol. 2012, 40:2004-2012.
9. Yang F., Zhang L., Huo X.S., Yuan J.H., Xu D., Yuan S.X., Zhu N., Zhou W.P., Yang G.S., Wang Y.Z., Shang J.L., Gao C.F., Zhang F.R., Wang F., Sun S.H. Long non-coding RNA high expressed in hepatocellular carcinoma (lncRNA-HEIH) facilitates tumor growth through enhancer of zeste homolog 2. Hepatology 2011, 54:1679-1689.
10. Tahira A.C., Kubrusly M.S., Faria M.F., Dazzani B., Fonseca R.S., Maracaja-Coutinho V., Verjovski-Almeida S., Machado M.C., Reis E.M. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol. Cancer 2011, 10:141.
11. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
12. O'Donoghue L.E., Ptitsyn A.A., Kamstock D.A., Siebert J., Thomas R.S., Duval D.L. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome. BMC Cancer 2010, 10:506.
13. Chen L.-L., Carmichael G.G. Decoding the function of nuclear long non-coding RNAs. Curr. Opin. Cell Biol. 2010, 22:357-364.
14. Dinger M.E., Arefin A.S., Berretta R., Moscato P. The hippocampal expression of 31 noncoding Rnas is upregulated in Alzheimer's disease patients and three positively correlate with MMSE results and other biomarkers of disease progression. Alzheimer's and Dementia 2010, 6:e47-e48.
15. Wang J.Y., Liu X.F., Wu H.C., Ni P.H., Gu Z.D., Qiao Y.X., Chen N., Sun F.Y., Fan Q.S. CREB up-regulates long noncoding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010, 38:5366-5383.
16. Lipovich L., Johnson R., Lin C.Y. MacroRNA underdogs in a microRNA world: Evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim. Biophys. Acta 2010, 1799:597-615.
17. Wang L.L. Biology of osteogenic sarcoma. Cancer J. 2005, 11:294-305.
18. Liu L.H., Li H., Li J.P., Zhong H., Zhang H.C., Chen J., Xiao T. MiR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem. Biophys. Res. Commun. 2011, 416:31-38.
19. Wang B., Fang L., Zhao H., Xiang T., Wang D. MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells. Acta Biochim. Biophys. Sin. 2012, 44:685-691.
20. Wu X., Cai Z.D., Lou L.M., Zhu Y.B. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients. Cancer Epidemiol. 2012, 36:212-216.